DRW Securities’s Bristol-Myers Squibb BMY Stock Holding History

DRW Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$373K	Sell	6,331 -1,376	-18%	-$80.2K	0.01%	770
2025 Q4	$416K	Buy	+7,707	New	+$371K	0.01%	524
2025 Q1	–	Sell	-5,056	Closed	-$285K	–	602
2024 Q4	$285K	Buy	+5,056	New	+$282K	0.01%	439
2024 Q2	–	Sell	-14,585	Closed	-$791K	–	536
2024 Q1	$791K	Buy	14,585 +1,856	+15%	+$94.5K	0.02%	197
2023 Q4	$653K	Buy	12,729 +8,740	+219%	+$459K	0.01%	171
2023 Q3	$232K	Sell	3,989 -912	-19%	-$55.9K	﹤0.01%	295
2023 Q2	$313K	Sell	4,901 -6,281	-56%	-$421K	0.01%	250
2023 Q1	$775K	Buy	+11,182	New	+$789K	0.01%	166
2022 Q4	–	Sell	-6,983	Closed	-$496K	–	269
2022 Q3	$496K	Buy	6,983 +4,249	+155%	+$308K	0.01%	148
2022 Q2	$211K	Sell	2,734 -9,020	-77%	-$687K	0.01%	228
2022 Q1	$858K	Buy	11,754 +5,983	+104%	+$402K	0.02%	137
2021 Q4	$360K	Buy	+5,771	New	+$339K	0.01%	168
2021 Q3	–	Sell	-6,929	Closed	-$463K	–	261
2021 Q2	$463K	Buy	+6,929	New	+$452K	0.01%	185
2020 Q2	–	Sell	-44,053	Closed	-$2.45M	–	181
2020 Q1	$2.45M	Buy	+44,053	New	+$2.69M	0.09%	57
2018 Q1	–	Sell	-22,944	Closed	-$1.41M	–	214
2017 Q4	$1.41M	Buy	+22,944	New	+$1.44M	0.15%	86
2013 Q3	–	Sell	-10,000	Closed	-$447K	–	170
2013 Q2	$447K	Buy	+10,000	New	+$434K	0.02%	144

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRW Securities's BMY Position: Q1 2026 in Review

DRW Securities reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, selling an estimated $80.2K and leaving 6,331 shares worth $373K. The position accounts for 0.01% of the portfolio, ranked #770.

DRW Securities first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.45M in Q1 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

DRW Securities held 6,331 shares of Bristol-Myers Squibb worth $373K as of Q1 2026.
DRW Securities sold 1,376 Bristol-Myers Squibb shares in Q1 2026, an estimated $80.2K.
Bristol-Myers Squibb made up 0.01% of DRW Securities's portfolio in Q1 2026, its #770 holding.
DRW Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
DRW Securities's Bristol-Myers Squibb position peaked at $2.45M in Q1 2020.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.